PerkinElmer Signals™ Translational: All is FAIR in Biomarker Discovery and Patient Stratification


Successful Clinical Outcomes start with unlocking your Biomarker Data.

Learn how PerkinElmer Signals Translational has helped Bristol Myers Squibb (BMS) with biomarker discovery and patient stratification whilst keeping the focus on F.A.I.R guidelines (Findable, Accessible, Interoperable, Reusable).

Watch this on-demand webinar to see how PerkinElmer Signals Translational can support your biomarker projects via:

  • Seamless data preparation and access for cross-study analysis
  • Search and aggregate study data(s) on the fly to create ad-hoc cohorts
  • Fully Integrated Translational Analytics (Powered by TIBCO Spotfire)
  • A collaborative framework for effective sharing of data, analytics and your biomarker driven insights